VEGF in 105 pheochromocytomas: Enhanced expression correlates with malignant outcome

APMIS

Volumn 111, Issue 4, 2003, Pages 458-464

  Salmenkivi, Kaisa ^a   Heikkilä, Päivi ^a   Liu, Jianqi ^a   Haglund, Caj ^b   Arola, Johanna ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Adrenal gland; Microvessel density; Pheochromocytoma; VEGF

Indexed keywords

CD34 ANTIGEN; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER LOCALIZATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULATURE; NORTHERN BLOTTING; OUTCOMES RESEARCH; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, NORTHERN; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHEOCHROMOCYTOMA; RNA, NEOPLASM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038378745     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.1110402.x     Document Type: Article

References (26)

1. Folkman J. What is the evidence that tumors are angiogenesis-dependent? J Natl Cancer Inst 1990;82:4-6.
2. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989;86:7311-5.
3. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-8.
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-91.
5. Shibuya M, Yamaguchi S, Yamane T, Ikeda T, Tojo A, Matsushime H, Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990;5:519-24.
6. Melicow MM. One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis. Cancer 1977;40:1987-2004.
7. Proye C, Vix M, Goropoulos A, Kerlo P, Lecomte-Houcke M. High incidence of malignant pheochromocytoma in a surgical unit. 26 cases out of 100 patients operated from 1971 to 1991. J Endocrinol Invest 1992;15:651-63.
8. Neville AM. The adrenal medulla. In: Symington T, editor. Functional Pathology of the Human Adrenal Gland. Baltimore, MD. Williams and Wilkins, 1969:217-324.
9. Lack EE. Adrenal medullary hyperplasia and pheochromocytoma. In: Lack EE, editor. Pathology of the Adrenal Glands. New York, Churchill Livingstone, 1990:173-235.
10. Linnoila RI, Keiser HR, Steinberg SM, Lack EE. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990;21:1168-80.
11. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
12. Liu J, Kahri AI, Heikkilä P, Blum WF, Voutilainen R. Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human phaechromocytoma cells. J Endocrinol 1994;142:29-35.
13. Jyung RW, LeClair EE, Bernat RA, Kang TS, Ung F McKenna MJ, Tuan RS. Expression of angiogenic growth factors in paragangliomas. Laryngoscope 2000;110:161-7.
14. Favier J, Plouin PF, Corvol P, Gasc JM. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 2002;161:1235-46.
15. Zielke A, Middeke M, Hoffmann S, Colombo-Benkmann M, Barth P, Hassan I, Wunderlich A, Hofbauer LC, Duh QY. VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors. Surgery 2002;132:1056-63; discussion 1063.
16. Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997;76:1410-5.
17. Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 1996;78:454-60.
18. Uchida S, Shimada Y, Watanabe G, Tanaka H, Shibagaki I, Miyahara T, Ishigami S, Arii S, Imamura M. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 1998;77:1704-9.
19. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999;79:1553-63.
20. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromoctyoma. Endocr Rev 1994;15:356-68.
21. Thompson LD. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 2002;26:551-66.
22. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-4.
23. Weidner N, Folkman J. Tumor vascularity as a prognostic factor in cancer. In: Rosenberg SA, editor. PPO Updates, Principles & Practice of Oncology. Philadelphia, J.B. Lippincott-Raven, 1996:1-24.
24. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
25. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388-93.
26. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-93.